Avidity Biosciences
RNAM
#1786
Rank
A$16.99 B
Marketcap
A$110.02
Share price
0.00%
Change (1 day)
40.90%
Change (1 year)

Avidity Biosciences (RNAM) - Total debt

Total debt on the balance sheet as of December 2025 : A$74.4 Million

According to Avidity Biosciences's latest financial reports the company's total debt is A$74.4 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Avidity Biosciences - Total debt on balance sheet (from 2019 to 2025)

Total debt by year

Year Total debt Change
2025-12-31A$73.53 M572.49%
2024-12-31A$10.93 M-24.39%
2023-12-31A$14.46 M-7.92%
2022-12-31A$15.7 M-2.93%
2021-12-31A$16.17 M1226.23%
2020-12-31A$1.21 M-82.7%
2019-12-31A$7.05 M-51.88%
2018-12-31A$14.65 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
A$95.47 B 128,210.09%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$47.49 B 63,732.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
A$1.58 B 2,023.51%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
A$1.05 B 1,314.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.11 B 53.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$0.29 B 297.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$4.05 M-94.56%๐Ÿ‡บ๐Ÿ‡ธ USA